FABP4 and cardiac hypertrophy: Circulating A-FABP levels were associated with myocardial perfusion abnormalities [129], positively correlated with left ventricular mass and hypertrophy [126,127] and were strongly correlated with N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP), a well-established biomarker of heart failure [130].